Biofarm S.A. (BVB:BIO)

Market Cap	1.23B +78.4%
Revenue (ttm)	319.33M +11.4%
Net Income	100.63M +35.3%
EPS	0.09 +34.3%
Shares Out	985.37M
PE Ratio	13.52
Forward PE	n/a
Dividend	0.03 (2.49%)
Ex-Dividend Date	May 13, 2026

Volume	21,093
Average Volume	53,785
Open	1.245
Previous Close	1.245
Day's Range	1.230 - 1.250
52-Week Range	0.620 - 1.355
Beta	0.52
RSI	49.14
Earnings Date	May 15, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 367
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2025, Biofarm's revenue was 319.33 million, an increase of 11.36% compared to the previous year's 286.77 million. Earnings were 100.63 million, an increase of 35.27%.